US Patent Issued to Duke University on May 26 for "Immunomodulating gene therapy" (North Carolina Inventor)

ALEXANDRIA, Va., May 26 -- United States Patent no. 12,636,302, issued on May 26, was assigned to Duke University (Durham, N.C.).

"Immunomodulating gene therapy" was invented by Dwight D. Koeberl (Durham, N.C.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates, in general, to Pompe disease and, in particular, to methods of treating Pompe disease and to compounds/constructs suitable for use in such methods."

The patent was filed on Dec. 27, 2022, under Application No. 18/146,999.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AN...